Jarett L. Feldman, M.D.
Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Gastrointestinal Medical Oncology, The University of Texas MD Anderson, Houston, Texas
Education & Training
Degree-Granting Education
| 2009 | The George Washington University School of Medicine and Health Sciences, Washington, D.C, District of Columbia, US, Doctor of Medicine |
| 2004 | Carnegie Mellon University, Pittsburgh, Pennsylvania, US, Chemical Engineering, Bachelor of Science |
Postgraduate Training
| 2012-2015 | Hematology & Oncology Fellow, Hematology & Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York |
| 2009-2012 | Internal Medicine Intern & Resident, Internal Medicine, Weill Cornell Medical College, New York, New York |
Licenses & Certifications
| 2025 | Florida Board of Medicine |
| 2025 | Georgia Composite Medical Board |
| 2025 | Oklahoma State Board of Medical Licensure |
| 2025 | Tennessee Board of Medical Examiners |
| 2025 | Arizona Board of Medical Examiners |
| 2025 | Louisiana State Board of Medical Examiners |
| 2025 | Alabama Board of Medical Examiners |
| 2025 | Texas Medical Board License |
| 2015 | Hematology Board Certification |
| 2015 | Medical Oncology Board Certification |
| 2012 | Internal Medicine Board Certification |
| 2012 | New York Division of Professional Licensing |
| null | Mississippi State Board of Medical Licensure |
Experience & Service
Other Professional Positions
Hematologist & Medical Oncologist, Summit Health, White Plains, New York, 2016 - 2025
Hematologist & Medical Oncologist, CareMount Medical Group, Mount Kisco, New York, 2015 - 2016
Editorial Contributor, Elsevier, Inc, 2014 - 2015
Health Policy Intern, United States Department of Health and Human Services, Washington, D.C, District of Columbia, 2006 - 2006
Pre-Cancer Research Training Award Fellow, National Cancer Institute, Bethesda, Maryland, 2004 - 2005
Honors & Awards
| 2015 | 2015 Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology |
| 2015 | 2015 ASCO Oncology Trainee Travel Award, American Society of Clinical Oncology |
| 2014 | 2014 AACR/ASCO Workshop, Methods in Clinical Cancer Research, American Association for Cancer Research/American Society of Clinical Oncology |
| 2014 | Clinical Research Methodology Curriculum Certificate Program, Memorial Sloan Kettering Cancer Center |
| 2014 | 2014 Conquer Cancer Foundation of ASCO Merit Award, American Society of Clinical Oncology |
| 2014 | C. Julian Rosenthal Travel Award, The New York State Society of Medical Oncologists and Hematologists |
| 2009 | Gold Humanism Honor Society, George Washington University |
| 2009 | William G. Schafhirt Award, George Washington University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Community Oncologist Perspective: Referrals & Pathways. Invited. Colorectal Cancer ctDNA Symposium: INTERCEPTing MRD Through Clinical Trials. Houston, Texas, US.
National Presentations
- 2026. Does Time from Radiographic Progression to the Start of a Clinical Trial Affect Outcomes in Metastatic Colorectal Cancer (mCRC)?. Poster. ASCO Quality Care Symposium. Houston, TX, US.
- 2026. Development of clinical criteria for primary oncology service involvement among solid tumor inpatients at MD Anderson Cancer Center. Poster. ASCO Quality Care Symposium.
- 2015. Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591. Poster. 2015 ASCO Genitourinary Cancers Symposium. New York, New York, US.
- 2014. Pathologic Correlation of 18F-16â-fluoro-5á-dihydrotestosterone (FDHT) and FDG PET in Patients with Metastatic Castration-Resistant Prostate Cancer. Poster. 2014 ASCO Annual Meeting. New York, New York, US.
- 2014. Evaluating 18F-16β-fluoro-5α-dihydrotestosterone (FDHT) and FDG PET as Prognostic Biomarkers for Patients Treated with Abiraterone Acetate. Poster. 2014 ASCO Genitourinary Cancers Symposium. New York, New York, US.
Selected Publications
Peer-Reviewed Articles
- McHugh D, Eisenberger M, Heath EI, Bruce J, Danila DC, Rathkopf DE, Feldman J, Slovin SF, Anand B, Chu R, Lackey J, Reyno L, Antonarakis ES, Morris MJ. A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer. Invest New Drugs 37(5):1052-1060, 2019. e-Pub 2019. PMID: 30725389.
- Feldman JL, Feldman JL, Heaney ML, Teruya-Feldstein J. Acute Myeloid Leukemia with t(9;11)(p22;q23) and Synchronous Langerhans Cell Histiocytosis. Int J Surg Pathol 22(2):172-176, 2014. e-Pub 2014. PMID: 23667134.
- Arlen PM, Skarupa L, Pazdur M, Seetharam M, Tsang KY, Grosenbach DW, Feldman J, Poole DJ, Litzinger M, Steinberg SM, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J, Gulley JL. Clinical Safety of a Viral Vector Based Prostate Cancer Vaccine Strategy. J. Urol 178(4):1515-1520, 2007. e-Pub 2007. PMID: 17707059.
- Arlen PM, Gulley JL, Parker C, Skarupa L, Pazdur M, Panicali D, Beetham P, Tsang KY, Grosenbach DW, Feldman J, Steinberg SM, Jones E, Chen C, Marte J, Schlom J, Dahut W. A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen independent prostate cancer. Clin Cancer Res 12(4):1260-1269, 2006. e-Pub 2006. PMID: 16489082.
Review Articles
- Proverbs-Singh T, Feldman JL, Morris MJ, Autio KA, A Traina AT. Targeting the Androgen Receptor in Prostate and Breast Cancer: Several New Agents in Development. Endocr Relat Cancer 22(3):R87-R106, 2015. e-Pub 2015. PMID: 25722318.
Other Articles
- Morgan RB, Neilson T, Keeling S, Kearse L, Brown K, Delisle M, Ochiai K, Helmink B, Song Y, Willis J, Shen JP, Hu I, Higbie VS, Feldman J, Morris V, Matura K, Sadasivan S, You Y, Bednarski B, Konishi T, Behman R, Moon J, Messick C, Guraieb-Trueba M, Ramamurthy J, Rodriguez-Bigas M, Chang GJ, Smith J, Mansfield P, Fournier K, White MG, Paula Marincola Smith MD Risk of Ovarian Metastasis in Colorectal Cancer-Related Carcinomatosis. Ann Surg Oncol, 2026.
Abstracts
- Feldman JL, Morris MJ, Martinez DF, Tagawa ST, Nanus DM, Solomon SB, Carrasquillo JA, Reuter VE, Lewis JS, O' Donoghue JA, Slovin SF, Rathkopf DE, Gonen M, Beylergil V, Durack JC, Cheal SM, Bander NH, Scher HI, Larson SM, Pandit-Taskar AN. Tumor-Directed PET Imaging of Metastases in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Using Zr-89 Labeled Antiprostate-Specific Membrane Antigen (PSMA) Antibody J591. 2015 ASCO Genitourinary Cancers Symposium 33(15), 2015. e-Pub 2015.
Book Chapters
- Feldman JL, Rahtkopf D, Morris MJ. The Androgen Receptor as a Therapeutic Target for Castration-Resistant Prostate Cancer. In: Management of Castration-Resistant Prostate Cancer. Springer, 77-94, 2014.
- Feldman JL, Bosl G. Germ Cell Tumor. In: Pocket Oncology. Lippincott Williams and Wilkins, 2014.
- Feldman JL, Motzer R. Renal Cell Carcinoma. In: Pocket Oncology. Lippincott Williams and Wilkins, 2014.
- Feldman JL, Matasar M. Fertility Preservation. In: Pocket Oncology. Lippincott Williams and Wilkins, 2014.
- Feldman JL, Matasar M. Tumor Lysis Syndrome. In: Pocket Oncology. Lippincott Williams and Wilkins, 2014.
- Grosenbach DW, Feldman J, Schlom J, I Abrams AS. Recombinant Viral and Bacterial Vaccines. In: General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology. 2007th. Springer, 2007.
Patient Reviews
CV information above last modified November 13, 2026